In another study involving 25 Asian individuals with EGFR‐TKI‐sensitive advanced lung cancer, the early administration of thoracic radiotherapy combined with targeted therapy substantially prolonged the drug resistance onset time. This evidence concerns the gene EGFR and lung cancer.